RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 52
SP 21
OP 22
DO 10.1177/155989771452013
UL http://mdc.sagepub.com/content/14/52/21.abstract
AB This article reports on the primary outcomes of the prospective, randomized, single-blind, multicenter EVOLVE II Clinical Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) [EVOLVE II; NCT01665053], which assessed the safety and effectiveness of 2 different everolimus-eluting stents, the second-generation SYNERGY stent and the PROMUS Element Plus durable-polymer drug-eluting stent.